Drug profile · INN
insulin degludec + insulin aspart
RYZODEG PENFILL
- Patents linked
- 0
- News articles
- 0
Quick answer
insulin degludec + insulin aspart (RYZODEG PENFILL) is an FDA-listed pharmaceutical active ingredient. Associated with NovoThirteen.
Key facts
Frequently asked questions
What is insulin degludec + insulin aspart?
insulin degludec + insulin aspart (RYZODEG PENFILL) is an FDA-listed pharmaceutical active ingredient. Associated with NovoThirteen.
What is the brand name for insulin degludec + insulin aspart?
RYZODEG PENFILL is a marketed brand name for insulin degludec + insulin aspart. Check FDA Drugs@FDA for the current US label holder and prescribing information.